Nanopublications

Matches in Nanopublications for { ?s ?p "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" ?g. }

Showing items 1 to 100 of ±180 with 100 items per page.

_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.
_3 value "We used cDNA microarrays to monitor the response of the endometriuim over 24 h following administration of mifepristone in the mid-secretory phase. Data taken from table 2. Fold change >= or <= 2.0, P < 0.05. 181 genes" provenance.